JP Morgan Chase
PBYI icon

JP Morgan Chase’s Puma Biotechnology PBYI Stock Holding History

JP Morgan Chase’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,000
Closed -$233K – 5937
2019
Q1 		$233K Buy
+6,000
New +$183K ﹤0.01% 4562
2018
Q2 		– Sell
-177,100
Closed -$12.1M – 5649
2018
Q1 		$12.1M Buy
+177,100
New +$13.3M ﹤0.01% 1889

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase's PBYI Position: Q2 2026 in Review

JP Morgan Chase reduced its Puma Biotechnology (PBYI) stake by 4.3% in Q2 2026, selling an estimated $68.7K and leaving 211,339 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #4289.

JP Morgan Chase first reported a position in PBYI in Q2 2013 and has held it in 53 quarters since. The position peaked at $65.8M in Q3 2014. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • JP Morgan Chase held 211,339 shares of Puma Biotechnology worth $1.73M as of Q2 2026.
  • JP Morgan Chase sold 9,385 Puma Biotechnology shares in Q2 2026, an estimated $68.7K.
  • Puma Biotechnology made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4289 holding.
  • JP Morgan Chase first reported a position in Puma Biotechnology in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Puma Biotechnology position peaked at $65.8M in Q3 2014.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.